The expression of PD-L1 has been shown to correlate with a poor prognosis in oesophageal cancer, pancreatic carcinoma, hepatocellular carcinoma, renal cell carcinoma and ovarian cancer [29,30,31,32,33,34]. This evidence concerns the gene CD274 and carcinoma of esophagus.